Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Miscellaneous Opioids
Agonists |
|
Cat.No. |
Product Name / Activity |
| 1650 | BAM 22P |
| Opioid receptor agonist. Also agonist at the sensory neuron specific receptor (SNSR) | |
| 1889 | [Leu5]-Enkephalin |
| Endogenous opioid agonist peptide | |
| 3137 | Neuropeptide FF |
| Antiopioid neuropeptide | |
Antagonists |
|
Cat.No. |
Product Name / Activity |
| 2965 | Diprenorphine |
| Non-selective opioid antagonist | |
| 4085 | Nalmefene hydrochloride |
| Opioid receptor antagonist | |
| 3971 | Nalmefene d3 |
| Deuterated nalmefene; opioid receptor antagonist | |
| 0599 | Naloxone hydrochloride |
| Broad spectrum opioid antagonist | |
| 0677 | Naltrexone hydrochloride |
| Broad spectrum opioid antagonist | |
Other |
|
Cat.No. |
Product Name / Activity |
| 2808 | Buprenorphine hydrochloride |
| Opioid receptor ligand | |
| 1929 | Melanocyte stimulating hormone release inhibiting factor |
| Antagonizes opioid effects in vivo. Also inhibits α-MSH release | |
| 1419 | Naloxone benzoylhydrazone |
| Full κ agonist, partial μ and δ agonist and antagonizes agonist-induced activation of NOP | |
| 1928 | Neuropeptide AF (human) |
| Antiopioid neuropeptide; modulates pain | |
| 1886 | Neuropeptide SF (human) |
| Antiopioid neuropeptide; modulates pain | |
| 3647 | Neuropeptide SF (mouse, rat) |
| Antiopioid neuropeptide; modulates pain | |






